FLUARIX 2025/2026 15 ug/.5mL
influenza virus vaccine · SUSPENSION · GlaxoSmithKline Biologicals SA
No Recall History
Plain English
FLUARIX 2025/2026 is a suspension containing influenza virus vaccine at 15 ug/.5mL, taken intramuscular. Manufactured by GlaxoSmithKline Biologicals SA.
Key Facts
- Brand Name
- FLUARIX 2025/2026
- Generic Name
- influenza virus vaccine
- NDC Code (Product)
58160-912- Manufacturer
- GlaxoSmithKline Biologicals SA
- Strength
- 15 ug/.5mL
- Dosage Form
- SUSPENSION
- Route
- INTRAMUSCULAR
- Marketing Status
- Application #
- BLA125127
- Marketing Start
- 07/01/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is FLUARIX 2025/2026 used for?
FLUARIX 2025/2026 contains influenza virus vaccine. It is a suspension taken intramuscular. Consult your doctor for specific uses.
Is FLUARIX 2025/2026 a controlled substance?
FLUARIX 2025/2026 is not classified as a controlled substance by the DEA.
What is the generic name for FLUARIX 2025/2026?
The generic name for FLUARIX 2025/2026 is influenza virus vaccine. There are 1 other brand versions of influenza virus vaccine.
What is the NDC code for FLUARIX 2025/2026 15 ug/.5mL?
The NDC (National Drug Code) for FLUARIX 2025/2026 15 ug/.5mL is 58160-912, listed by GlaxoSmithKline Biologicals SA.